Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Canna Delivery Systems is a biotechnology company specializing in advanced drug delivery technologies for the cannabis and life sciences sectors. As a subsidiary of Core One Labs, the company developed the CannaStrips platform, an oral thin-film technology that provides a smokeless, accurately metered, and rapidly absorbed alternative to traditional cannabis consumption. The technology allows for the infusion of cannabinoids like CBD and THC into thin strips that dissolve in the mouth, with effects typically manifesting within 5 to 15 minutes. Canna Delivery Systems licenses its intellectual property to manufacturing partners in legal jurisdictions to produce standardized medical and recreational products. The company's delivery platform is also being leveraged for the administration of other therapeutic compounds, including psychedelic substances like psilocybin for mental health indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canna Delivery Systems.